Dr Reddy's Laboratories to launch Penicillamine capsules in US market
Dr Reddy's Laboratories to launch Penicillamine capsules in US market

Dr Reddy's Laboratories to launch Penicillamine capsules in US market

DSIJ Intelligence Article rating: 5.0

Dr Reddy’s Laboratories Ltd announced the launch of Penicillamine capsules USP, 250 mg, a therapeutic equivalent generic version of Cuprimine (Penicillamine) capsules, 250 mg, approved by United States Food & Drug Administration (USFDA) on Thursday.

Sensex, Nifty positive, IndusInd bank zooms 6.59 per cent, HDFC, Axis Bank and M&M contribute the most to Sensex gains
Sensex, Nifty positive, IndusInd bank zooms 6.59 per cent, HDFC, Axis Bank and M&M contribute the most to Sensex gains

Sensex, Nifty positive, IndusInd bank zooms 6.59 per cent, HDFC, Axis Bank and M&M contribute the most to Sensex gains

DSIJ Intelligence Article rating: 4.3

On the last expiry day of the month, Sensex and Nifty saw profit booking. Sensex managed to close at 39113.47 levels, up by 39.55 points or 0.10 per cent on Thursday. Nifty closed at 11559.25 levels, up by 9.65 points or 0.08 per cent.

Future Group stocks lock in at upper circuits, Future Retail zooms by 11 per cent
Future Group stocks lock in at upper circuits, Future Retail zooms by 11 per cent

Future Group stocks lock in at upper circuits, Future Retail zooms by 11 per cent

DSIJ Intelligence Article rating: 3.4

Future Enterprises Ltd (FEL) announced that a meeting of the company’s board of directors is scheduled to be held for considering proposals of raising funds. Reacting to the announcement, the shares of various Future Group-owned companies soared high on Thursday.

RSS
First27952796279727982800280228032804Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR